Page last updated: 2024-10-15

plantaricin a

Description

plantaricin A: from Lactobacillus plantarum; its activity depends on the action of two peptides [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133082076
MeSH IDM0224336

Synonyms (2)

Synonym
plantaricin a
131463-18-8

Research Excerpts

Overview

Plantaricin A (PlnA) is a 26-mer peptide pheromone with membrane-permeabilizing, strain-specific antibacterial activity. It is produced by Lactobacillus plantarum C11.

ExcerptReference
"Plantaricin A (PlnA) is a peptide pheromone with membrane permeabilizing strain-specific antibacterial activity, produced by Lactobacillus plantarum C11."( Plantaricin A, a peptide pheromone produced by Lactobacillus plantarum, permeabilizes the cell membrane of both normal and cancerous lymphocytes and neuronal cells.
Blomhoff, HK; Iijima, T; Naderi, S; Nissen-Meyer, J; Ohara, S; Oppegård, C; Sand, O; Sand, SL, 2010
)
"Plantaricin A (PlnA) is a peptide with antimicrobial and pheromone activities. "( The antimicrobial peptide pheromone Plantaricin A increases antioxidant defenses of human keratinocytes and modulates the expression of filaggrin, involucrin, β-defensin 2 and tumor necrosis factor-α genes.
Calasso, M; De Angelis, M; Di Cagno, R; Giuliani, G; Gobbetti, M; Marzani, B; Minervini, F; Pinto, D, 2012
)
"Plantaricin A (plA) is a 26-residue bacteria-produced peptide pheromone with membrane-permeabilizing antimicrobial activity. "( Interaction of the antimicrobial peptide pheromone Plantaricin A with model membranes: implications for a novel mechanism of action.
Bose, S; Fimland, G; Jutila, A; Kinnunen, PK; Nissen-Meyer, J; Sood, R; Zhao, H, 2006
)
"Plantaricin A (PlnA) is a 26-mer peptide pheromone with membrane-permeabilizing, strain-specific antibacterial activity, produced by Lactobacillus plantarum C11. "( The bacterial peptide pheromone plantaricin A permeabilizes cancerous, but not normal, rat pituitary cells and differentiates between the outer and inner membrane leaflet.
Haug, TM; Nissen-Meyer, J; Sand, O; Sand, SL, 2007
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (25.00)18.2507
2000's5 (20.83)29.6817
2010's10 (41.67)24.3611
2020's3 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (8.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (92.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]